Archives

In 2006, MDA funded the first gene therapy trial for Duchenne muscular dystrophy, paving the way for more neuromuscular disease treatments.

MDA has always received vital support from volunteers, with almost 2,000 people volunteering at MDA events in the past year.

MDA plays a key role in a new frontier of medicine looking into how to regenerate muscles lost to neuromuscular disease.

Leading researchers on GNE myopathy discuss what is known about this neuromuscular disease and the search for effective therapies.

Mashauna Black, who lives with limb-girdle muscular dystrophy (LGMD), found a new path to pursue her dream of working in healthcare.

How disability benefits are affected by employment and how to work with eligibility and income restrictions.

When a child is diagnosed with a neuromuscular disease, it impacts siblings, too. Here’s how to help them cope and build resilience.

These often-overlooked accessibility features and apps can enhance your smartphone experience.

Glycogen storage diseases (GSDs) are a group of rare inherited conditions that occur when the body is not able to use or store glycogen properly. People with GSDs may experience…

MDA’s Development Grants to support early-career scientists are vital to driving innovation in neuromuscular disease research.